Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H, Rana S, Sharma P, Bose PL, Yadav DD, Sachdeva MUS, Varma N, Trehan A, Lad D, Khadwal AR, Malhotra P, Sreedharanunni S. Virk H, et al. Among authors: rana s. Ann Hematol. 2021 Aug;100(8):2031-2041. doi: 10.1007/s00277-021-04574-0. Epub 2021 Jun 22. Ann Hematol. 2021. PMID: 34159401
An Evaluation of a Fluorescence In Situ Hybridization Strategy Using Air-dried Blood and Bone-marrow Smears in the Risk Stratification of Pediatric B-Lineage Acute Lymphoblastic Leukemia in Resource-limited Settings.
Sharma P, Rana S, Sreedharanunni S, Gautam A, Sachdeva MUS, Naseem S, Varma N, Jain R, Bansal D, Trehan A. Sharma P, et al. Among authors: rana s. J Pediatr Hematol Oncol. 2021 May 1;43(4):e481-e485. doi: 10.1097/MPH.0000000000001892. J Pediatr Hematol Oncol. 2021. PMID: 32769569
The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - Results from a single centre pilot study.
Gautam A, Sreedharanunni S, Sachdeva MUS, Rana S, Kashyap D, Bose P, Bal A, Prakash G, Malhotra P, Das R, Varma N. Gautam A, et al. Among authors: rana s. Int J Lab Hematol. 2021 Oct;43(5):1123-1131. doi: 10.1111/ijlh.13467. Epub 2021 Jan 17. Int J Lab Hematol. 2021. PMID: 33455071
The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India.
Sharma P, Rana S, Virk H, Sachdeva MUS, Sharma P, Varma N, Jain R, Bansal D, Trehan A, Khadwal AR, Malhotra P, Sreedharanunni S. Sharma P, et al. Among authors: rana s. Leuk Lymphoma. 2022 Oct;63(10):2474-2478. doi: 10.1080/10428194.2021.1929964. Epub 2021 May 24. Leuk Lymphoma. 2022. PMID: 34027795 No abstract available.
Paratrabecular myelofibrosis and occult mastocytosis are strong morphological clues to suspect FIP1L1-PDGFRA translocation in hypereosinophilia.
Sreedharanunni S, Sachdeva MUS, Sharma S, Rana S, Sandal R, Kumar N, Sharma P, Naseem S, Ahluwalia J, Das R, Malhotra P, Varma N. Sreedharanunni S, et al. Among authors: rana s. Indian J Hematol Blood Transfus. 2020 Apr;36(2):384-389. doi: 10.1007/s12288-019-01236-0. Epub 2019 Dec 4. Indian J Hematol Blood Transfus. 2020. PMID: 32425395 Free PMC article.
The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia.
Virk H, Rana S, Kapadia AB, Sreedharanunni S, Mallik N, Kumar N, Sharma P, Naseem S, Sachdeva MUS, Ahluwalia J, Das R, Varma N, Malhotra P. Virk H, et al. Among authors: rana s. Int J Lab Hematol. 2020 Dec;42(6):e287-e290. doi: 10.1111/ijlh.13322. Epub 2020 Aug 27. Int J Lab Hematol. 2020. PMID: 32851767 Clinical Trial. No abstract available.
2,343 results